Immunology Remains a Large Underserved Market
Millions of Patients Do Not Have Access to Advanced Systemic Therapies



                                             Untreated
                                            ~62M (39%)



    ~160M
                                                            Advanced
                                                            Therapies    >$100B
     PATIENTS                                                ~5M (3%)    IN ANNUAL SALES
  DIAGNOSED WITH                                                          FOR ADVANCED
  IMMUNOLOGICAL                                                             THERAPIES2
     DISEASES1

                                           Non-Advanced
                                             Therapies
                                            ~90M (58%)



                                                                                           5
